Showing results (261-270 of 2,503) with videos related to

Sort By:
Pageof 251
Endocrine-Related Cancer|May 28, 2004
Chronic thyrotropin-suppressive therapy with levothyroxine and short-term overt hypothyroidism after thyroxine withdrawal are associated with undesirable cardiovascular effects in patients with differentiated thyroid carcinomaJosé I Botella-Carretero, Manuel Gómez-Bueno, Vivencio Barrios, et al.
Endocrine-Related Cancer|December 18, 2009
Glucocorticoid receptor over-expression promotes human small cell lung cancer apoptosis in vivo and thereby slows tumor growthPaula Sommer, Rachel L Cowen, Andrew Berry, et al.
Endocrine-Related Cancer|December 8, 2009
Selective recruitment of breast cancer anti-estrogen resistance genes and relevance for breast cancer progression and tamoxifen therapy responseTon van Agthoven, Anieta M Sieuwerts, Danielle Meijer, et al.
Endocrine-Related Cancer|December 17, 2009
Leptin-R and its association with PI3K/AKT signaling pathway in papillary thyroid carcinomaShahab Uddin, Prashant Bavi, Abdul K Siraj, et al.
Endocrine-Related Cancer|December 3, 2005
Emerging role of the endothelin axis in ovarian tumor progressionAnna Bagnato, Francesca Spinella, Laura Rosanò
Endocrine-Related Cancer|December 3, 2005
Juvenile differentiated thyroid carcinoma and the role of radioiodine in its treatment: a qualitative reviewB Jarzab, D Handkiewicz-Junak, J Wloch
Endocrine-Related Cancer|December 3, 2005
High-mobility group A2 gene expression is frequently induced in non-functioning pituitary adenomas (NFPAs), even in the absence of chromosome 12 polysomyGiovanna Maria Pierantoni, Palma Finelli, Emanuele Valtorta, et al.
Endocrine-Related Cancer|December 3, 2005
Differential expression of IGF-binding protein-3 in normal and malignant colon and its influence on apoptosisP J Jenkins, S Khalaf, W Ogunkolade, et al.
Endocrine-Related Cancer|December 3, 2005
Disappearance of a virilizing adrenal tumor following therapy with cyproterone acetateA Lasco, E Morini, D Maglitto, et al.
Endocrine-Related Cancer|December 3, 2005
The p53-homologue p63 may promote thyroid cancer progressionRoberta Malaguarnera, Angelo Mandarino, Emanuela Mazzon, et al.
Pageof 251